(Q45077717)

English

Phosphodiesterase-5 inhibitors and migraine

scientific article published in October 2004

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15447704

retrieved

9 December 2017

title

Phosphodiesterase-5 inhibitors and migraine (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9 December 2017

1

Randolph W Evans

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9 December 2017

C Kruuse

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15447704

retrieved

9 December 2017

publication date

1 October 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

15447704

retrieved

9 December 2017

volume

44

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15447704

retrieved

9 December 2017

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15447704

retrieved

9 December 2017

page(s)

925-926

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15447704

retrieved

9 December 2017

cites work

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04177.X

retrieved

21 January 2018

The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04177.X

retrieved

21 January 2018

Migraine can be induced by sildenafil without changes in middle cerebral artery diameter

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2004.04177.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1526-4610.2004.04177.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15447704

retrieved

9 December 2017

PubMed publication ID

15447704

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15447704

retrieved

9 December 2017

(Q45077717)

Phosphodiesterase-5 inhibitors and migraine

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)